May 23, 2014
An executive of the Japan Pharmaceutical Manufacturers Association (JPMA) cast his doubt on an apparent inconsistency between a proposal made by government panel members to annually revise NHI drug prices and Prime Minister Shinzo Abe’s economic growth strategy that aims...read more